increas
case
around
world
urgent
need
background
increas
case
around
world
urgent
need
effect
therapeut
drug
necessari
therefor
conduct
pilot
randomizedcontrol
studi
evalu
efficaci
tcmdp
therapeut
treatment
method
total
mild
patient
enrol
pilot
rct
februari
march
assign
ratio
control
patient
tcmdp
group
patient
patient
control
group
receiv
routin
treatment
patient
assign
tcmdp
group
receiv
combin
routin
treatment
administr
tcmdp
inject
patient
control
tcmdp
group
treat
day
primari
end
point
ctbase
radiolog
pulmonari
chang
followup
find
baselin
day
mild
patient
tcmdp
group
signific
radiolog
improv
lung
declin
inflammatori
infiltr
wherea
patient
control
group
radiolog
improv
lung
none
patient
tcmdp
group
diseas
progress
mild
sever
well
inflammatori
cytokin
storm
mild
patient
control
group
develop
sever
day
number
patient
radiolog
improv
tcmdp
group
remain
consist
addit
case
control
group
report
random
pilot
studi
tcmdp
effect
inhibitori
effect
inflammatori
diseas
progress
therapi
acceler
absorpt
pulmonari
inflamm
short
period
time
process
treatment
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
recent
outbreak
novel
coronaviru
current
begin
spread
mani
countri
around
world
becom
pandem
accord
world
health
organ
increas
case
fatal
highlight
urgent
need
effect
therapeut
drug
would
prevent
progress
diseas
especi
decreas
deterior
rate
respiratori
pulmonari
infect
process
cytokin
storm
trig
excess
inflammatori
respons
macrophag
activ
lead
multipl
organ
damag
even
fatal
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
treat
day
primari
end
point
ctbase
radiolog
pulmonari
chang
baselin
day
secondari
end
point
diseas
progress
mild
sever
day
well
radiolog
pulmonari
chang
day
day
treatment
demograph
characterist
similar
two
group
except
patient
control
group
older
tcmdp
group
median
age
year
vs
year
fewer
women
control
group
tcmdp
group
vs
tabl
tabl
conclus
random
pilot
studi
clinic
drug
tcmdp
effect
inhibitori
effect
inflammatori
diseas
progress
mild
sever
therapi
acceler
absorpt
pulmonari
inflamm
short
period
time
process
treatment
besid
seriou
advers
event
includ
bodi
immun
clinic
use
tcmdp
addit
potenti
advantag
applic
tcmdp
avoid
excess
use
glucocorticoid
treatment
sever
patient
order
prevent
incid
glucocorticoid
caus
complic
osteonecrosi
femor
head
limit
small
sampl
size
larger
longer
trial
warrant
determin
efficaci
tcmdp
treatment
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
figur
comput
tomographi
ct
base
radiograph
patient
lung
top
shown
pulmonari
radiograph
one
patient
tcmdp
group
admiss
day
b
day
c
bottom
shown
pulmonari
radiograph
one
patient
control
group
admiss
day
e
day
f
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
